Johnson & Johnson (JNJ) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Johnson & Johnson, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$271.04
+0.86% today
Market cap
$646.9B
Overall quality
—
Kronos AI 30-day
−2.2%
0 of 8 simulated paths end higher
Johnson & Johnson (JNJ) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $646.9B. It trades at $271.04, up 0.86% today. 17 analysts' average target of $287.88 implies +6.2% from today's price. Kronos AI's 30-day forecast is −2.2% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $287.88 |
| Low – high | $260.00 – $320.00 |
| Analysts | 17 |
| Upside to average | +6.2% |
Kronos AI 30-day forecast
| Expected close | $258.05 (−2.2%) |
| Likely range | −6.6% … −1.0% |
| As of | 2026-10-26 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Passes |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.